Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05663203 · ClinicalTrials.gov registry record · NA
A Web-Based Dyadic Intervention for Colorectal Cancer
A NA study of Colorectal Carcinoma, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT05663203: Recruiting NA study of Colorectal Carcinoma, sponsored by Emory University.
NCT05663203 is a NA study of Colorectal Carcinoma that is actively recruiting participants, run by Emory University. The registered enrollment target is 56 participants, below the 1,095-participant average among 53 other Colorectal Carcinoma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05663203, a NA study of Colorectal Carcinoma, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies how well a web-based dyadic intervention works to manage psychoneurological symptoms for patients with colorectal cancer and their caregivers. Patients with colorectal cancer receiving chemotherapy experience severe and distressing psychoneurological symptoms that include fatigue, depression, sleep disturbance, pain, and cognitive dysfunction. When these co-occurring symptoms are undertreated, they negatively affect functional status, survival rates, and quality of life of patients as well as decrease health outcomes of their family caregiver. A critical need exists to develop an effective and novel intervention that focuses on patients with colorectal cancer receiving chemotherapy and their caregivers. A web-based dyadic intervention holds great promise to reduce psychoneurological symptoms burden and improve quality of life for patients with colorectal cancer receiving chemotherapy and advance intervention development and implementation in cancer supportive care and health equity.
Primary Outcome
Collect attendance records from each dyad before and after modules. The intervention will be considered to be high attrition if \> 80% dyads remain enrolled. Feasibility of study participation will be assessed by calculating retention rates, identifying reasons for refusal and assessing completeness of the data.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Electronic Health Record Review
- OTHER Interview
- OTHER Internet-Based Intervention
Study Locations (1)
Georgia
- Emory University/Winship Cancer Institute - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2027-10-01 |
| Phase | NA |
What NCT05663203 shows while recruiting
NCT05663203 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,095-participant average among 53 other Colorectal Carcinoma trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Colorectal Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Survey Administration is the first listed.
NCT05663203 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05663203 about?
NCT05663203 is a clinical study titled "A Web-Based Dyadic Intervention for Colorectal Cancer". This clinical trial studies how well a web-based dyadic intervention works to manage psychoneurological symptoms for patients with colorectal cancer and their caregivers. Patients with colorectal cancer receiving chemotherapy experience severe and distressing psychoneurological symptoms that include...
What is the current status of trial NCT05663203?
This trial is currently recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2023-05-01. Estimated completion is 2027-10-01.
What conditions does trial NCT05663203 study?
This clinical trial studies the following conditions: Colorectal Carcinoma.
What interventions are being tested in trial NCT05663203?
The interventions under investigation include: Survey Administration (OTHER), Electronic Health Record Review (OTHER), Interview (OTHER), Internet-Based Intervention (OTHER).
Who is sponsoring clinical trial NCT05663203?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05663203 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05663203's enrollment target sits among peer trials
56 38th of 53 higher than 16 of 53 other Colorectal Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
RECRUITING · NA
-
Confronting Cancer as a Community
RECRUITING · NA
-
CoGENES Randomized Controlled Trial (RCT)
RECRUITING · NA
-
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
RECRUITING · NA
-
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
RECRUITING · NA
-
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI